 | • レポートコード：GIR-107A14373 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、血管形成モジュレーターのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。血管形成モジュレーターの種類別市場規模（血管形成阻害剤、血管形成刺激剤、アンギオゲニン、その他）、用途別市場規模（乳がん、結腸直腸がん、肺がん、前立腺がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・血管形成モジュレーターの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Celgene Corporation (USA)、Eisai (Japan)、Amgen, Inc. (USA)、Genentech, Inc. (USA)、GlaxoSmithKline plc (UK)、Bayer Pharma AG (Germany)、Bionomics Ltd. (Australia)、CASI Pharmaceuticals, Inc. (USA)、AstraZeneca plc (UK)、Eli Lilly and Company (USA)、F.Hoffmann-La Roche AG (Switzerland) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：血管形成阻害剤、血管形成刺激剤、アンギオゲニン、その他 ・用途別分析2016年-2026年：乳がん、結腸直腸がん、肺がん、前立腺がん、その他 ・血管形成モジュレーターの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・血管形成モジュレーターのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・血管形成モジュレーターのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・血管形成モジュレーターの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・血管形成モジュレーターの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Angiogenesis Modulators market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Angiogenesis Modulators size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Angiogenesis Modulators market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Angiogenesis Modulators market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Angiogenesis Inhibitors
Angiogenesis Stimulators
Angiogenin
Others
Market segment by Application can be divided into
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Others
The key market players for global Angiogenesis Modulators market are listed below:
Celgene Corporation (USA)
Eisai (Japan)
Amgen, Inc. (USA)
Genentech, Inc. (USA)
GlaxoSmithKline plc (UK)
Bayer Pharma AG (Germany)
Bionomics Ltd. (Australia)
CASI Pharmaceuticals, Inc. (USA)
AstraZeneca plc (UK)
Eli Lilly and Company (USA)
F.Hoffmann-La Roche AG (Switzerland)
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Angiogenesis Modulators product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Angiogenesis Modulators, with price, sales, revenue and global market share of Angiogenesis Modulators from 2019 to 2021.
Chapter 3, the Angiogenesis Modulators competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Angiogenesis Modulators breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Angiogenesis Modulators market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Angiogenesis Modulators sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Angiogenesis Modulators Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Angiogenesis Modulators Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Angiogenesis Inhibitors
1.2.3 Angiogenesis Stimulators
1.2.4 Angiogenin
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Angiogenesis Modulators Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Lung Cancer
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Global Angiogenesis Modulators Market Size & Forecast
1.4.1 Global Angiogenesis Modulators Sales in Value (2016-2026))
1.4.2 Global Angiogenesis Modulators Sales in Volume (2016-2026)
1.4.3 Global Angiogenesis Modulators Price by Type (2016-2026) & (USD/MT)
1.5 Global Angiogenesis Modulators Production Capacity Analysis
1.5.1 Global Angiogenesis Modulators Total Production Capacity (2016-2026)
1.5.2 Global Angiogenesis Modulators Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Angiogenesis Modulators Market Drivers
1.6.2 Angiogenesis Modulators Market Restraints
1.6.3 Angiogenesis Modulators Trends Analysis
2 Manufacturers Profiles
2.1 Celgene Corporation (USA)
2.1.1 Celgene Corporation (USA) Details
2.1.2 Celgene Corporation (USA) Major Business
2.1.3 Celgene Corporation (USA) Angiogenesis Modulators Product and Services
2.1.4 Celgene Corporation (USA) Angiogenesis Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Eisai (Japan)
2.2.1 Eisai (Japan) Details
2.2.2 Eisai (Japan) Major Business
2.2.3 Eisai (Japan) Angiogenesis Modulators Product and Services
2.2.4 Eisai (Japan) Angiogenesis Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Amgen, Inc. (USA)
2.3.1 Amgen, Inc. (USA) Details
2.3.2 Amgen, Inc. (USA) Major Business
2.3.3 Amgen, Inc. (USA) Angiogenesis Modulators Product and Services
2.3.4 Amgen, Inc. (USA) Angiogenesis Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Genentech, Inc. (USA)
2.4.1 Genentech, Inc. (USA) Details
2.4.2 Genentech, Inc. (USA) Major Business
2.4.3 Genentech, Inc. (USA) Angiogenesis Modulators Product and Services
2.4.4 Genentech, Inc. (USA) Angiogenesis Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 GlaxoSmithKline plc (UK)
2.5.1 GlaxoSmithKline plc (UK) Details
2.5.2 GlaxoSmithKline plc (UK) Major Business
2.5.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Product and Services
2.5.4 GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Bayer Pharma AG (Germany)
2.6.1 Bayer Pharma AG (Germany) Details
2.6.2 Bayer Pharma AG (Germany) Major Business
2.6.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Product and Services
2.6.4 Bayer Pharma AG (Germany) Angiogenesis Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Bionomics Ltd. (Australia)
2.7.1 Bionomics Ltd. (Australia) Details
2.7.2 Bionomics Ltd. (Australia) Major Business
2.7.3 Bionomics Ltd. (Australia) Angiogenesis Modulators Product and Services
2.7.4 Bionomics Ltd. (Australia) Angiogenesis Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 CASI Pharmaceuticals, Inc. (USA)
2.8.1 CASI Pharmaceuticals, Inc. (USA) Details
2.8.2 CASI Pharmaceuticals, Inc. (USA) Major Business
2.8.3 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product and Services
2.8.4 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 AstraZeneca plc (UK)
2.9.1 AstraZeneca plc (UK) Details
2.9.2 AstraZeneca plc (UK) Major Business
2.9.3 AstraZeneca plc (UK) Angiogenesis Modulators Product and Services
2.9.4 AstraZeneca plc (UK) Angiogenesis Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Eli Lilly and Company (USA)
2.10.1 Eli Lilly and Company (USA) Details
2.10.2 Eli Lilly and Company (USA) Major Business
2.10.3 Eli Lilly and Company (USA) Angiogenesis Modulators Product and Services
2.10.4 Eli Lilly and Company (USA) Angiogenesis Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 F.Hoffmann-La Roche AG (Switzerland)
2.11.1 F.Hoffmann-La Roche AG (Switzerland) Details
2.11.2 F.Hoffmann-La Roche AG (Switzerland) Major Business
2.11.3 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product and Services
2.11.4 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Angiogenesis Modulators Sales by Manufacturer
3.1 Global Angiogenesis Modulators Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Angiogenesis Modulators Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Angiogenesis Modulators
3.4 Market Concentration Rate
3.4.1 Top 3 Angiogenesis Modulators Manufacturer Market Share
3.4.2 Top 6 Angiogenesis Modulators Manufacturer Market Share
3.5 Global Angiogenesis Modulators Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Angiogenesis Modulators Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Angiogenesis Modulators Market Size by Region
4.1.1 Global Angiogenesis Modulators Sales in Volume by Region (2016-2026)
4.1.2 Global Angiogenesis Modulators Revenue by Region (2016-2026)
4.2 North America Angiogenesis Modulators Revenue (2016-2026)
4.3 Europe Angiogenesis Modulators Revenue (2016-2026)
4.4 Asia-Pacific Angiogenesis Modulators Revenue (2016-2026)
4.5 South America Angiogenesis Modulators Revenue (2016-2026)
4.6 Middle East and Africa Angiogenesis Modulators Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Angiogenesis Modulators Sales in Volume by Type (2016-2026)
5.2 Global Angiogenesis Modulators Revenue by Type (2016-2026)
5.3 Global Angiogenesis Modulators Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Angiogenesis Modulators Sales in Volume by Application (2016-2026)
6.2 Global Angiogenesis Modulators Revenue by Application (2016-2026)
6.3 Global Angiogenesis Modulators Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Angiogenesis Modulators Sales by Type (2016-2026)
7.2 North America Angiogenesis Modulators Sales by Application (2016-2026)
7.3 North America Angiogenesis Modulators Market Size by Country
7.3.1 North America Angiogenesis Modulators Sales in Volume by Country (2016-2026)
7.3.2 North America Angiogenesis Modulators Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Angiogenesis Modulators Sales by Type (2016-2026)
8.2 Europe Angiogenesis Modulators Sales by Application (2016-2026)
8.3 Europe Angiogenesis Modulators Market Size by Country
8.3.1 Europe Angiogenesis Modulators Sales in Volume by Country (2016-2026)
8.3.2 Europe Angiogenesis Modulators Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Angiogenesis Modulators Sales by Type (2016-2026)
9.2 Asia-Pacific Angiogenesis Modulators Sales by Application (2016-2026)
9.3 Asia-Pacific Angiogenesis Modulators Market Size by Region
9.3.1 Asia-Pacific Angiogenesis Modulators Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Angiogenesis Modulators Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Angiogenesis Modulators Sales by Type (2016-2026)
10.2 South America Angiogenesis Modulators Sales by Application (2016-2026)
10.3 South America Angiogenesis Modulators Market Size by Country
10.3.1 South America Angiogenesis Modulators Sales in Volume by Country (2016-2026)
10.3.2 South America Angiogenesis Modulators Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Angiogenesis Modulators Sales by Type (2016-2026)
11.2 Middle East & Africa Angiogenesis Modulators Sales by Application (2016-2026)
11.3 Middle East & Africa Angiogenesis Modulators Market Size by Country
11.3.1 Middle East & Africa Angiogenesis Modulators Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Angiogenesis Modulators Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Angiogenesis Modulators Typical Distributors
12.3 Angiogenesis Modulators Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Angiogenesis Modulators Revenue by Type, (USD Million), 2021-2026
Table 2. Global Angiogenesis Modulators Revenue by Application, (USD Million), 2021-2026
Table 3. Celgene Corporation (USA) Basic Information, Manufacturing Base and Competitors
Table 4. Celgene Corporation (USA) Major Business
Table 5. Celgene Corporation (USA) Angiogenesis Modulators Product and Services
Table 6. Celgene Corporation (USA) Angiogenesis Modulators Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Eisai (Japan) Basic Information, Manufacturing Base and Competitors
Table 8. Eisai (Japan) Major Business
Table 9. Eisai (Japan) Angiogenesis Modulators Product and Services
Table 10. Eisai (Japan) Angiogenesis Modulators Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Amgen, Inc. (USA) Basic Information, Manufacturing Base and Competitors
Table 12. Amgen, Inc. (USA) Major Business
Table 13. Amgen, Inc. (USA) Angiogenesis Modulators Product and Services
Table 14. Amgen, Inc. (USA) Angiogenesis Modulators Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Genentech, Inc. (USA) Basic Information, Manufacturing Base and Competitors
Table 16. Genentech, Inc. (USA) Major Business
Table 17. Genentech, Inc. (USA) Angiogenesis Modulators Product and Services
Table 18. Genentech, Inc. (USA) Angiogenesis Modulators Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GlaxoSmithKline plc (UK) Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline plc (UK) Major Business
Table 21. GlaxoSmithKline plc (UK) Angiogenesis Modulators Product and Services
Table 22. GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bayer Pharma AG (Germany) Basic Information, Manufacturing Base and Competitors
Table 24. Bayer Pharma AG (Germany) Major Business
Table 25. Bayer Pharma AG (Germany) Angiogenesis Modulators Product and Services
Table 26. Bayer Pharma AG (Germany) Angiogenesis Modulators Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bionomics Ltd. (Australia) Basic Information, Manufacturing Base and Competitors
Table 28. Bionomics Ltd. (Australia) Major Business
Table 29. Bionomics Ltd. (Australia) Angiogenesis Modulators Product and Services
Table 30. Bionomics Ltd. (Australia) Angiogenesis Modulators Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. CASI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base and Competitors
Table 32. CASI Pharmaceuticals, Inc. (USA) Major Business
Table 33. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product and Services
Table 34. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. AstraZeneca plc (UK) Basic Information, Manufacturing Base and Competitors
Table 36. AstraZeneca plc (UK) Major Business
Table 37. AstraZeneca plc (UK) Angiogenesis Modulators Product and Services
Table 38. AstraZeneca plc (UK) Angiogenesis Modulators Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Eli Lilly and Company (USA) Basic Information, Manufacturing Base and Competitors
Table 40. Eli Lilly and Company (USA) Major Business
Table 41. Eli Lilly and Company (USA) Angiogenesis Modulators Product and Services
Table 42. Eli Lilly and Company (USA) Angiogenesis Modulators Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. F.Hoffmann-La Roche AG (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 44. F.Hoffmann-La Roche AG (Switzerland) Major Business
Table 45. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product and Services
Table 46. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Angiogenesis Modulators Sales by Manufacturer (2019-2021e) & (K MT)
Table 48. Global Angiogenesis Modulators Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Angiogenesis Modulators, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Angiogenesis Modulators Production Capacity by Company, (K MT): 2020 VS 2021
Table 51. Head Office and Angiogenesis Modulators Production Site of Key Manufacturer
Table 52. Angiogenesis Modulators New Entrant and Capacity Expansion Plans
Table 53. Angiogenesis Modulators Mergers & Acquisitions in the Past Five Years
Table 54. Global Angiogenesis Modulators Sales by Region (2016-2021e) & (K MT)
Table 55. Global Angiogenesis Modulators Sales by Region (2021-2026) & (K MT)
Table 56. Global Angiogenesis Modulators Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Angiogenesis Modulators Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Angiogenesis Modulators Sales by Type (2016-2021e) & (K MT)
Table 59. Global Angiogenesis Modulators Sales by Type (2021-2026) & (K MT)
Table 60. Global Angiogenesis Modulators Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Angiogenesis Modulators Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Angiogenesis Modulators Price by Type (2016-2021e) & (USD/MT)
Table 63. Global Angiogenesis Modulators Price by Type (2021-2026) & (USD/MT)
Table 64. Global Angiogenesis Modulators Sales by Application (2016-2021e) & (K MT)
Table 65. Global Angiogenesis Modulators Sales by Application (2021-2026) & (K MT)
Table 66. Global Angiogenesis Modulators Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Angiogenesis Modulators Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Angiogenesis Modulators Price by Application (2016-2021e) & (USD/MT)
Table 69. Global Angiogenesis Modulators Price by Application (2021-2026) & (USD/MT)
Table 70. North America Angiogenesis Modulators Sales by Country (2016-2021e) & (K MT)
Table 71. North America Angiogenesis Modulators Sales by Country (2021-2026) & (K MT)
Table 72. North America Angiogenesis Modulators Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Angiogenesis Modulators Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Angiogenesis Modulators Sales by Type (2016-2021e) & (K MT)
Table 75. North America Angiogenesis Modulators Sales by Type (2021-2026) & (K MT)
Table 76. North America Angiogenesis Modulators Sales by Application (2016-2021e) & (K MT)
Table 77. North America Angiogenesis Modulators Sales by Application (2021-2026) & (K MT)
Table 78. Europe Angiogenesis Modulators Sales by Country (2016-2021e) & (K MT)
Table 79. Europe Angiogenesis Modulators Sales by Country (2021-2026) & (K MT)
Table 80. Europe Angiogenesis Modulators Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Angiogenesis Modulators Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Angiogenesis Modulators Sales by Type (2016-2021e) & (K MT)
Table 83. Europe Angiogenesis Modulators Sales by Type (2021-2026) & (K MT)
Table 84. Europe Angiogenesis Modulators Sales by Application (2016-2021e) & (K MT)
Table 85. Europe Angiogenesis Modulators Sales by Application (2021-2026) & (K MT)
Table 86. Asia-Pacific Angiogenesis Modulators Sales by Region (2016-2021e) & (K MT)
Table 87. Asia-Pacific Angiogenesis Modulators Sales by Region (2021-2026) & (K MT)
Table 88. Asia-Pacific Angiogenesis Modulators Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Angiogenesis Modulators Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Angiogenesis Modulators Sales by Type (2016-2021e) & (K MT)
Table 91. Asia-Pacific Angiogenesis Modulators Sales by Type (2021-2026) & (K MT)
Table 92. Asia-Pacific Angiogenesis Modulators Sales by Application (2016-2021e) & (K MT)
Table 93. Asia-Pacific Angiogenesis Modulators Sales by Application (2021-2026) & (K MT)
Table 94. South America Angiogenesis Modulators Sales by Country (2016-2021e) & (K MT)
Table 95. South America Angiogenesis Modulators Sales by Country (2021-2026) & (K MT)
Table 96. South America Angiogenesis Modulators Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Angiogenesis Modulators Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Angiogenesis Modulators Sales by Type (2016-2021e) & (K MT)
Table 99. South America Angiogenesis Modulators Sales by Type (2021-2026) & (K MT)
Table 100. South America Angiogenesis Modulators Sales by Application (2016-2021e) & (K MT)
Table 101. South America Angiogenesis Modulators Sales by Application (2021-2026) & (K MT)
Table 102. Middle East & Africa Angiogenesis Modulators Sales by Country (2016-2021e) & (K MT)
Table 103. Middle East & Africa Angiogenesis Modulators Sales by Country (2021-2026) & (K MT)
Table 104. Middle East & Africa Angiogenesis Modulators Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Angiogenesis Modulators Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Angiogenesis Modulators Sales by Type (2016-2021e) & (K MT)
Table 107. Middle East & Africa Angiogenesis Modulators Sales by Type (2021-2026) & (K MT)
Table 108. Middle East & Africa Angiogenesis Modulators Sales by Application (2016-2021e) & (K MT)
Table 109. Middle East & Africa Angiogenesis Modulators Sales by Application (2021-2026) & (K MT)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Angiogenesis Modulators Typical Distributors
Table 113. Angiogenesis Modulators Typical Customers
List of Figures
Figure 1. Angiogenesis Modulators Picture
Figure 2. Global Angiogenesis Modulators Sales Market Share by Type in 2020
Figure 3. Angiogenesis Inhibitors
Figure 4. Angiogenesis Stimulators
Figure 5. Angiogenin
Figure 6. Others
Figure 7. Global Angiogenesis Modulators Sales Market Share by Application in 2020
Figure 8. Breast Cancer
Figure 9. Colorectal Cancer
Figure 10. Lung Cancer
Figure 11. Prostate Cancer
Figure 12. Others
Figure 13. Global Angiogenesis Modulators Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 14. Global Angiogenesis Modulators Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Angiogenesis Modulators Sales (2016-2026) & (K MT)
Figure 16. Global Angiogenesis Modulators Price by Type (2016-2026) & (USD/MT)
Figure 17. Global Angiogenesis Modulators Production Capacity (2016-2026) & (K MT)
Figure 18. Global Angiogenesis Modulators Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Angiogenesis Modulators Market Drivers
Figure 20. Angiogenesis Modulators Market Restraints
Figure 21. Angiogenesis Modulators Market Trends
Figure 22. Global Angiogenesis Modulators Sales Market Share by Manufacturer in 2020
Figure 23. Global Angiogenesis Modulators Revenue Market Share by Manufacturer in 2020
Figure 24. Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Angiogenesis Modulators Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Angiogenesis Modulators Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Angiogenesis Modulators Sales Market Share by Region (2016-2026)
Figure 28. Global Angiogenesis Modulators Revenue Market Share by Region (2016-2026)
Figure 29. North America Angiogenesis Modulators Revenue (2016-2026) & (USD Million)
Figure 30. Europe Angiogenesis Modulators Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Angiogenesis Modulators Revenue (2016-2026) & (USD Million)
Figure 32. South America Angiogenesis Modulators Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Angiogenesis Modulators Revenue (2016-2026) & (USD Million)
Figure 34. Global Angiogenesis Modulators Sales Market Share by Type (2016-2026)
Figure 35. Global Angiogenesis Modulators Revenue Market Share by Type (2016-2026)
Figure 36. Global Angiogenesis Modulators Price by Type (2016-2026) & (USD/MT)
Figure 37. Global Angiogenesis Modulators Sales Market Share by Application (2016-2026)
Figure 38. Global Angiogenesis Modulators Revenue Market Share by Application (2016-2026)
Figure 39. Global Angiogenesis Modulators Price by Application (2016-2026) & (USD/MT)
Figure 40. North America Angiogenesis Modulators Sales Market Share by Type (2016-2026)
Figure 41. North America Angiogenesis Modulators Sales Market Share by Application (2016-2026)
Figure 42. North America Angiogenesis Modulators Sales Market Share by Country (2016-2026)
Figure 43. North America Angiogenesis Modulators Revenue Market Share by Country (2016-2026)
Figure 44. United States Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Angiogenesis Modulators Sales Market Share by Type (2016-2026)
Figure 48. Europe Angiogenesis Modulators Sales Market Share by Application (2016-2026)
Figure 49. Europe Angiogenesis Modulators Sales Market Share by Country (2016-2026)
Figure 50. Europe Angiogenesis Modulators Revenue Market Share by Country (2016-2026)
Figure 51. Germany Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Angiogenesis Modulators Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Angiogenesis Modulators Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Angiogenesis Modulators Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Angiogenesis Modulators Revenue Market Share by Region (2016-2026)
Figure 60. China Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Angiogenesis Modulators Sales Market Share by Type (2016-2026)
Figure 67. South America Angiogenesis Modulators Sales Market Share by Application (2016-2026)
Figure 68. South America Angiogenesis Modulators Sales Market Share by Country (2016-2026)
Figure 69. South America Angiogenesis Modulators Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Angiogenesis Modulators Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Angiogenesis Modulators Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Angiogenesis Modulators Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Angiogenesis Modulators Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Angiogenesis Modulators Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の前立腺がん市場 2021：企業別、地域別、種類・用途別 The Prostate Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…- 世界の腎臓がん治療薬市場 2021：企業別、地域別、種類・用途別 The Kidney Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の乳がん用チューブリン阻害剤市場 2021：企業別、地域別、種類・用途別 The Tubulin Inhibitors for Breast Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界の肺がん治療薬市場 2021：企業別、地域別、種類・用途別 The Lung Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の乳がん診断・薬物技術市場 2021：企業別、地域別、種類・用途別 The Breast Cancer Diagnostic and Drug Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…